发明名称 |
Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia |
摘要 |
The present disclosure relates, in general, to methods of treating or preventing hypoglycemia using a negative modulator antibody fragment that binds to the insulin receptor and modulates the action of insulin at the insulin receptor. |
申请公布号 |
US2017037135(A1) |
申请公布日期 |
2017.02.09 |
申请号 |
US201615230340 |
申请日期 |
2016.08.05 |
申请人 |
XOMA (US) LLC |
发明人 |
Rubin Paul;Takeuchi Toshihiko;Issafras Hassan;Ahluwalia Kiranjit;Corbin John;Goldfine Ira;Johnson Kirk;Li Ou;Bedinger Daniel |
分类号 |
C07K16/28;A61K45/06;A61K39/395 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. An antibody or fragment thereof comprising three heavy chain CDRs having the amino acid sequence set out in SEQ ID NOs: 5-7, 8-10 and 50-112 and three light chain CDRs have the amino acid sequences set out in SEQ ID NOs: 14-16 or SEQ ID NOs: 20-28 wherein the antibody or fragment thereof binds to i) insulin receptor or (ii) a complex comprising insulin and insulin receptor, or both (i) and (ii). |
地址 |
Berkeley CA US |